Literature DB >> 20399906

Jejunal cancer in patients with familial adenomatous polyposis.

Anthony T Ruys1, Yasser A Alderlieste, Dirk J Gouma, Evelien Dekker, Elisabeth M H Mathus-Vliegen.   

Abstract

BACKGROUND & AIMS: Familial adenomatous polyposis (FAP) is an inherited disease affecting approximately 1:10,000 newborns, characterized by the formation of numerous adenomas in the digestive tract. Surveillance and prophylactic treatment of colonic and duodenal manifestations of this disease have much influenced disease course and survival. In more recent years, it has become clear that adenoma formation in FAP patients is not restricted to the colon and duodenum. Accordingly, these adenomas might have malignant potential, although the actual risk is unknown.
METHODS: We report 3 cases of jejunal carcinoma in FAP patients and review data on incidence, prognosis, and risk factors of jejunoileal adenoma and carcinoma development in FAP.
RESULTS: Three patients with FAP aged 71, 57, and 59 years developed advanced duodenal adenomatosis and a jejunal carcinoma, which was associated with poor prognosis in 2 patients.
CONCLUSIONS: Jejunal adenomas in FAP patients are reported occasionally and can progress into adenocarcinoma with a poor prognosis. In the future a subset of FAP patients benefitting from jejunal surveillance should be identified. Copyright 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20399906     DOI: 10.1016/j.cgh.2010.04.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Surveillance using capsule endoscopy is safe in post-colectomy patients with familial adenomatous polyposis: a prospective Japanese study.

Authors:  Minori Matsumoto; Takeshi Nakajima; Yasuo Kakugawa; Taku Sakamoto; Shiko Kuribayashi; Yosuke Otake; Takahisa Matsuda; Yukihide Kanemitsu; Hirokazu Taniguchi; Yutaka Saito
Journal:  Fam Cancer       Date:  2016-01       Impact factor: 2.375

2.  Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.

Authors:  Seth Septer; Caitlin E Lawson; Shrikant Anant; Thomas Attard
Journal:  Fam Cancer       Date:  2016-07       Impact factor: 2.375

3.  Prospective enteroscopic evaluation of jejunal polyposis in patients with familial adenomatous polyposis and advanced duodenal polyposis.

Authors:  Y A Alderlieste; E A J Rauws; E M H Mathus-Vliegen; P Fockens; E Dekker
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

4.  Role of endoscopy in patients with familial adenomatous polyposis.

Authors:  Andrew D Hopper
Journal:  Frontline Gastroenterol       Date:  2022-06-08

5.  Multiple jejunal cancers resulting from combination of germline APC and MLH1 mutations.

Authors:  Noralane M Lindor; Tom C Smyrk; Sheila Buehler; Shanaka R Gunawardena; Brittany C Thomas; Paul Limburg; Salman Kirmani; Stephen N Thibodeau
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

6.  Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution.

Authors:  Yuichiro Watanabe; Hideyuki Ishida; Hiroyuki Baba; Takeo Iwama; Atsushi Kudo; Minoru Tanabe; Hideki Ishikawa
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

Review 7.  Small bowel adenocarcinoma - report of two cases and review of literature.

Authors:  Philip Umman; Vineeth Adiyodi; Chanchal Narayan
Journal:  Indian J Surg       Date:  2012-06-16       Impact factor: 0.656

Review 8.  Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update.

Authors:  Hiroyuki Aihara; Nitin Kumar; Christopher C Thompson
Journal:  Eur J Gastroenterol Hepatol       Date:  2014-03       Impact factor: 2.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.